Enzalutamide monotherapy in Hormone-Naïve Prostate Cancer

Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer.

Posted in Active Surveillance, Hormonal Blockade, Metastatic Disease, Prostate Cancer, Treatments for Prostate Cancer | Tagged , , | Leave a comment

Cryo Immuno Therapy Part 3

Part 3 of the lecture about Cryo Immune Therapy given by Dr. Israel  Barken from the Prostate Research and Education Foundation.  Dr. Barken describes Cryo immunotherapy. The reasons why there are no consistent immune response after cryoablation are discussed.  Suggestions for further research to enhance the cryoablation immune activation are brought up, based on pre clinical research on the subject.  This is the third lecture to demonstrating further evidence of the cryo immunology phenomena.

Posted in Cryo Immunotherapy, Cryoablation, Immune Therapy, Metastatic Prostate Cancer Disease, Prostate Cancer, Treatments for Prostate Cancer | Leave a comment

Cryo Immunotherapy Part 2

Part 2 of the lecture about Cryo Immune Therapy given by Dr. Israel  Barken from the Prostate Research and Education Foundation.  Dr. Barken describes Cryo immunotherapy. The reasons why there are no consistent immune response after cryoablation are discussed.  Suggestions for further research to enhance the cryoablation immune activation are brought up, based on pre clinical research on the subject.  This is the second lecture to be followed up by further evidence of the cryo immunology phenomena.

Posted in Cryo Immunotherapy, Cryoablation, Prostate Cancer, Treatments for Prostate Cancer | Leave a comment

Cryo Immunotherapy Part 1

Dr. Barken presents the history of cryoablation and the new developments in the field of immunology which will create enhancement of the Immune effect on metastatic disease in response to cryoablation of local tumor.

Posted in Cryo Immunotherapy, Cryoablation, Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer, Vaccine | Leave a comment

Cryoablation Immuno Therapy

Clinical Study Phase I Cryoimmunotherapy against Metastatic prostate Cancer Disease.


Dr. Israel Barken, the Medical Director of the Prostate Cancer Research and Education, presents a clinical study phase I, featuring cryosurgery plus immuno-Modulator – Cyclophosphamide and Anti CTLA 4 Antibodies- Ipilimumab (Yervoy)

Posted in Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Prostate Cancer, Treatments for Prostate Cancer, Vaccine | Leave a comment

Combining active immunotherapy and immune checkpoint inhibitors in prostate cancer

Phase I study approach of priming the immune system with Prostvac vaccination, intensified immunotherapy with Ipilimumab to further enhance the immune response.  This was presented by Hapreet Singh M.D. from the National Cancer Institute.

Genentech video explaining the “Security Checkpoint System” is incorporated in the video presentation above. You can view it separately by clicking on the Video below.

 

Posted in Ask Dr. Barken, Immune Therapy, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer, Vaccine | Leave a comment

Percentage Involved Core Length and Risk of Recurrence After Radical Prostatectomy

Article: Greatest Percentage Involved Core Length and Risk of Clinically Significant Prostate-Specific Antigen Failure After Radical Prostatectomy.

Author:  Anthony V. D’Amico

Source: Clinical Genitourinary Cancer.  March 5, 2015

Posted in Biopsy, Prognosis, Prostate Cancer, PSA, Survival prostate cancer, Treatments for Prostate Cancer | Leave a comment